Analysts count on revenue increase Biogen

Tomorrow Biogen will publish its past quarters results. Over the current book year the total revenue will be 14,25 billion USD (consensus estimates). This is slightly more than 2018's revenue of 13,45 billion USD.

Historical revenues and results Biogen plus estimates 2020

The analysts expect for 2020 a net profit of 6,26 billion USD. According to most of the analysts the company will have a profit per share for this book year of 33,18 USD. The price/earnings-ratio therefore equals 8,5.

Analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies is a good 2,29381636379435 percent.

Biogen's market capitalization is based on the number of outstanding shares around 59,63 billion USD. The Biogen stock was the past 12 months quite volatile. Since last January the stock is 16 percent lower. This year the stock price moved between 216 and 339 dollar. Since 2008 the stock price is almost 470 percent higher.

Historical stock prices Biogen from 2007 till 2020

Click here for dividend . At 18.22 the stock trades 0,16 percent lower at 281,95 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.